[Novel animal models for bullous pemphigoid utilized by "humanization of autoantigen"]
- PMID: 20046014
- DOI: 10.2177/jsci.32.472
[Novel animal models for bullous pemphigoid utilized by "humanization of autoantigen"]
Abstract
Animal models of human diseases are very useful to better understand their pathomechanism and to develop new therapies. However, due to the differences among different species, it is sometimes difficult to reproduce reliable diseases phenotype in animals. Bullous pemphigoid is the most common autoimmune blistering skin disease, in which circulating IgG autoantibodies directed against type XVII collagen (COL17) leads to skin blister formation. Interestingly, due to significant interspecies differences in its amino acid sequences in major pathogenic epitope on COL17, passive transfer of auto-antibodies (Abs) from patients with bullous pemphigoid into mice failed to induce blister formation. To overcome this species' differences, we have recently established a novel molecular method "humanization of autoantigen" by genetic manipulation. Using COL17-humanized mice, we have established 2 different mouse models of bullous pemphigoid. One is by injecting human auto-Abs from bullous pemphigoid patients into the neonatal COL17-humanized mice. Another model was induced by mouse Abs to human COL17 passively transferred from mother via placenta and milk into the neonatal COL17-humanized mice. "Humanization of autoantigen" is a novel and potential method to produce animal models for autoimmune diseases.
Similar articles
-
A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen.J Immunol. 2010 Feb 15;184(4):2166-74. doi: 10.4049/jimmunol.0903101. Epub 2010 Jan 20. J Immunol. 2010. PMID: 20089696
-
Mouse models of autoimmune blistering diseases induced by the passive transfer of antibodies.Methods Mol Biol. 2013;961:363-9. doi: 10.1007/978-1-62703-227-8_24. Methods Mol Biol. 2013. PMID: 23325657
-
Bullous pemphigoid autoantibodies directly induce blister formation without complement activation.J Immunol. 2014 Nov 1;193(9):4415-28. doi: 10.4049/jimmunol.1400095. Epub 2014 Sep 26. J Immunol. 2014. PMID: 25261486
-
IgE autoantibodies in bullous pemphigoid: supporting role, or leading player?J Dermatol Sci. 2015 Apr;78(1):5-10. doi: 10.1016/j.jdermsci.2015.03.002. Epub 2015 Mar 9. J Dermatol Sci. 2015. PMID: 25797172 Review.
-
Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII.J Dermatol Sci. 2014 Mar;73(3):179-86. doi: 10.1016/j.jdermsci.2013.12.001. Epub 2013 Dec 27. J Dermatol Sci. 2014. PMID: 24434029 Review.
Cited by
-
Animal models of skin disease for drug discovery.Expert Opin Drug Discov. 2013 Mar;8(3):331-55. doi: 10.1517/17460441.2013.761202. Epub 2013 Jan 8. Expert Opin Drug Discov. 2013. PMID: 23293893 Free PMC article. Review.